MLLcoprotein水平影响白血病血统身份
Derek H Janssens1,2, Melodie Duran1, Dominik J Otto1,3
1Basic Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Nature communications
|October 30, 2024
概括
混合血统白血病 (MLL) coproteins驱动着不同的白血病计划. 通过MLLcoproteins的动态染色体结合可能会促进谱系切换和对精子抑制剂的抵抗.
科学领域:
- * 血液瘤学
- * 分子生物学 * 分子生物学
- * 基因调控 * 基因调控
背景情况:
- *染色体转位涉及混合系白血病 (MLL) 位点产生强大的瘤性融合蛋白 (coproteins).
- *这些MLL瘤蛋白破坏了发育基因表达的调节,导致白血病.
- * 特定的融合合作伙伴会影响coprotein的基结合和致癌潜力.
研究的目的:
- * 研究MLL重组白血病中MLLcoprotein点位的基因组丰富和动态调节.
- * 了解MLL瘤蛋白如何激活不同的急性淋巴细胞白血病 (ALL) 或急性髓性白血病 (AML) 程序.
- * 探索MLLcoproteins在治疗诱导的血统切换和潜在的抵抗机制中的作用.
主要方法:
- * 在36个MLL重新排列的白血病样本中对coprotein目标部位的分析.
- *分析了因治疗诱导的淋巴细胞转移为骨髓细胞的样本.
- * 对基因表达程序的coprotein水平和染色质占用率的评估.
主要成果:
- *MLLcoprotein基因组丰富是高度可变的,并在样本之间动态调节.
- *高coprotein水平激活ALL (亲B细胞基因) 或AML (造血干细胞基因) 程序,与融合伴侣患病率相关.
- * 血统切换样本显示蛋白水平降低和颗粒细胞-单细胞原始体 (GMP) 基因的优先激活.
- * 在一个案例中,尽管在revumenib治疗期间无法检测到coprotein和menin水平,但ENL在目标位点上持续存在.
结论:
- *MLLcoproteins通过动态染色质结合在特定的基因对象基因促进谱系切换事件.
- * 染色质占用量的变化可能会导致对阴膜抑制剂的耐药性.
- *了解这些机制对于开发针对性治疗MLL重组型白血病至关重要.
相关概念视频
Lineage Commitment
3.0K
Commitment is the process whereby stem cells:
3.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
Disorders of Leukocytes
895
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
895
Induced Pluripotent Stem Cells
3.9K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
3.9K


